sirolimus (TAVT-18) / Tavanta Therap  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
sirolimus (TAVT-18) / Tavanta Therap
STOP2, NCT04595513: Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants

Completed
1/2
5
US
TAVT-18 (sirolimus)
Children's Hospital Medical Center, Cincinnati
Tuberous Sclerosis Complex, Epilepsy
12/22
12/22

Download Options